Valeant Near Deal to Acquire Bausch & Lomb: Source

Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch & Lomb Holdings Inc from Warburg Pincus LLC for about $9 billion, Reuters reports.

24 May 2013•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles